No Data
No Data
UroGen Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/01/2024 257.57% HC Wainwright & Co. $60 → $60 Reiterates Buy → Buy 06/14/2024 218.83% Ladenburg Thalman
H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $60
H.C. Wainwright analyst Ram Selvaraju maintains $UroGen Pharma Ltd(URGN.US)$ with a buy rating, and maintains the target price at $60.According to TipRanks data, the analyst has a success rate of 36.9
TD Cowen Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Announces Target Price $102
TD Cowen analyst Tara Bancroft maintains $UroGen Pharma Ltd(URGN.US)$ with a buy rating, and sets the target price at $102.According to TipRanks data, the analyst has a success rate of 50.0% and a tot
Goldman Sachs Maintains UroGen Pharma Ltd(URGN.US) With Hold Rating, Maintains Target Price $22
Goldman Sachs analyst Paul Choi maintains $UroGen Pharma Ltd(URGN.US)$ with a hold rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success rate of 52.1% and
UroGen Pharma Stock Slumps After Pricing Stock and Warrants Offering
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.2% on Tuesday.Shares of NextEra Energy, Inc. (NYSE:NEE) fell sharply in today's pre-market trading after the compan
No Data